Current Trends in the Gene Therapy of Hematologic Disorders

Recent advances in molecular genetics and the invention of new technologies led to an advance in the development of gene therapy. Gene therapy is used to correct defective genes in order to cure a disease or help the body better fight a disease. It works by restoring or modifying cellular functions...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Nikolova D.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2021
Materias:
R
Acceso en línea:https://doaj.org/article/8bfc36e42aee48cb9182a12ab93d3cc2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8bfc36e42aee48cb9182a12ab93d3cc2
record_format dspace
spelling oai:doaj.org-article:8bfc36e42aee48cb9182a12ab93d3cc22021-12-05T14:11:06ZCurrent Trends in the Gene Therapy of Hematologic Disorders2719-538410.2478/amb-2021-0048https://doaj.org/article/8bfc36e42aee48cb9182a12ab93d3cc22021-11-01T00:00:00Zhttps://doi.org/10.2478/amb-2021-0048https://doaj.org/toc/2719-5384Recent advances in molecular genetics and the invention of new technologies led to an advance in the development of gene therapy. Gene therapy is used to correct defective genes in order to cure a disease or help the body better fight a disease. It works by restoring or modifying cellular functions through the introduction of a functional gene into the target cell. The concept of gene therapy is simple, but introducing it to routine clinical practice is not. The main concerns are related to some safety issues as well as to the problem that maintaining a stable and prolonged expression in target cells may not be easily achieved. In spite of the difficulties, gene therapy remains a hope for many hematological disorders that cannot be effectively treated so far. This article reviews the current status of gene therapy with a focus on hematological disorders. In addition, clinically applied approaches are presented through particular examples of approved gene therapy drugs.Nikolova D.Sciendoarticlegene therapyhematological diseasesgene therapy drugsMedicineRENActa Medica Bulgarica, Vol 48, Iss 4, Pp 50-56 (2021)
institution DOAJ
collection DOAJ
language EN
topic gene therapy
hematological diseases
gene therapy drugs
Medicine
R
spellingShingle gene therapy
hematological diseases
gene therapy drugs
Medicine
R
Nikolova D.
Current Trends in the Gene Therapy of Hematologic Disorders
description Recent advances in molecular genetics and the invention of new technologies led to an advance in the development of gene therapy. Gene therapy is used to correct defective genes in order to cure a disease or help the body better fight a disease. It works by restoring or modifying cellular functions through the introduction of a functional gene into the target cell. The concept of gene therapy is simple, but introducing it to routine clinical practice is not. The main concerns are related to some safety issues as well as to the problem that maintaining a stable and prolonged expression in target cells may not be easily achieved. In spite of the difficulties, gene therapy remains a hope for many hematological disorders that cannot be effectively treated so far. This article reviews the current status of gene therapy with a focus on hematological disorders. In addition, clinically applied approaches are presented through particular examples of approved gene therapy drugs.
format article
author Nikolova D.
author_facet Nikolova D.
author_sort Nikolova D.
title Current Trends in the Gene Therapy of Hematologic Disorders
title_short Current Trends in the Gene Therapy of Hematologic Disorders
title_full Current Trends in the Gene Therapy of Hematologic Disorders
title_fullStr Current Trends in the Gene Therapy of Hematologic Disorders
title_full_unstemmed Current Trends in the Gene Therapy of Hematologic Disorders
title_sort current trends in the gene therapy of hematologic disorders
publisher Sciendo
publishDate 2021
url https://doaj.org/article/8bfc36e42aee48cb9182a12ab93d3cc2
work_keys_str_mv AT nikolovad currenttrendsinthegenetherapyofhematologicdisorders
_version_ 1718371370843242496